Llp Abingworth's Net Worth

Estimate Recalculated May 19, 2025 08:11PM EST

Who is Llp Abingworth

Llp Abingworth does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., AMARIN CORP PLC\UK, Vera Therapeutics, Inc., Sierra Oncology, Inc., Personalis, Inc., Sientra, Inc., Jasper Therapeutics, Inc., SOLENO THERAPEUTICS INC, eFFECTOR Therapeutics, Inc., PROTEON THERAPEUTICS INC, and CHIASMA, INC.

SEC CIK

Llp Abingworth's CIK is 0001397144

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vaxcyte, Inc.

Investor

Updated Jun 16, 2020

View Quote Details


Form 4/A	—	40.00K	—	—	Jun 16, 2020	40.00K	Grant	—	Jun 11
Form 4	-50.00%	-40.00K	—	—	Jun 15, 2020	40.00K	Grant	—	Jun 11
Form 3	—	—	—	—	Jun 11, 2020	—	—	—	—

Showing 3 results

AMARIN CORP PLC\UK

Investor

Updated Apr 26, 2012

View Quote Details


Form 4/A	-71.48%	-4.01M	$9.62	-$38.55M	Apr 26, 2012	1.60M	Sale	—	Apr 17 - Apr 19
Form 4	-71.48%	-4.01M	$9.62	-$38.55M	Apr 19, 2012	1.60M	Sale	—	Apr 17 - Apr 19
Form 4	-29.09%	-2.30M	$11.00	-$25.30M	Apr 05, 2012	5.61M	Sale	—	Apr 03
Form 4	0.15%	11.68K	—	—	Dec 22, 2011	8.00M	Acquisition	—	Dec 20
Form 3	—	—	—	—	May 09, 2011	7.90M	—	—	—
Form 4	-34.61%	-4.18M	$14.87	-$62.14M	Apr 20, 2011	7.90M	Sale	Scheduled	Apr 18
Form 4	-18.55%	-2.75M	$7.50	-$20.64M	Mar 15, 2011	12.08M	Sale	—	Mar 11
Form 4	-3.58%	-550.00K	$7.50	-$4.13M	Mar 10, 2011	14.83M	Sale	—	Mar 08
Form 4	-0.65%	-100.00K	$7.60	-$760.00K	Mar 08, 2011	15.38M	Sale	—	Mar 04
Form 4	-7.20%	-1.20M	$7.70	-$9.24M	Mar 04, 2011	15.48M	Sale	—	Mar 02
Form 4	-1.91%	-325.00K	$7.87	-$2.56M	Mar 02, 2011	16.68M	Sale	—	Feb 28 - Mar 01
Form 3	—	—	—	—	Jan 05, 2011	17.00M	—	—	—
Form 3	—	—	—	—	Oct 26, 2009	17.00M	—	—	—

Showing 13 results

Vera Therapeutics, Inc.

Investor

Updated Aug 19, 2022

View Quote Details


Form 4	-0.33%	-9.93K	$15.63	-$91.85K	Aug 19, 2022	2.96M	Sale	—	Aug 17
Form 4	—	2.97M	$11.00	—	May 18, 2021	2.97M	Purchase	—	May 13 - May 18
Form 3	—	—	—	—	May 13, 2021	—	—	—	—

Showing 3 results

Sierra Oncology, Inc.

Investor

Updated Feb 01, 2022


Form 4	12.89%	150.00K	$17.93	$7.84M	Feb 01, 2022	1.31M	Purchase	—	Jan 28 - Jan 31
Form 3	—	—	—	—	Nov 05, 2021	878.66K	—	—	—

Showing 2 results

Personalis, Inc.

Investor

Updated Oct 21, 2020

View Quote Details


Form 4	-3.36%	-130.49K	$27.66	-$3.61M	Oct 21, 2020	3.75M	Sale	—	Oct 20
Form 4	-6.96%	-290.64K	$27.48	-$7.99M	Oct 20, 2020	3.88M	Sale	—	Oct 16 - Oct 19
Form 4	-2.01%	-85.63K	$27.05	-$2.32M	Oct 16, 2020	4.17M	Sale	—	Oct 14 - Oct 15
Form 4	-4.53%	-202.36K	$28.81	-$5.83M	Oct 14, 2020	4.26M	Sale	—	Oct 12 - Oct 13
Form 4	-18.11%	-986.84K	$19.00	-$18.75M	Aug 20, 2020	4.46M	Sale	—	Aug 18
Form 4	—	—	—	—	Jun 26, 2019	5.45M	Options	—	Jun 24
Form 3	—	—	—	—	Jun 19, 2019	188.64K	—	—	—

Showing 7 results

Sientra, Inc.

Investor

Updated May 09, 2018

View Quote Details


Form 4	12.80%	281.48K	$13.50	$3.80M	May 09, 2018	2.48M	Purchase	—	May 07
Form 3/A	—	—	—	—	Nov 04, 2014	—	—	—	—
Form 4	29.05%	495.00K	$15.00	$7.43M	Oct 31, 2014	2.20M	Purchase	—	Oct 29
Form 3	—	—	—	—	Oct 28, 2014	1.70M	—	—	—

Showing 4 results

Jasper Therapeutics, Inc.

Investor

Updated Feb 12, 2024

View Quote Details


Form 4	21.68%	190.00K	$12.95	$2.46M	Feb 12, 2024	1.07M	Purchase	—	Feb 08
Form 4	55.67%	3.13M	$1.50	$4.70M	Jan 31, 2023	8.76M	Purchase	—	Jan 27
Form 4	—	78.05K	—	—	Mar 23, 2022	78.05K	Grant	—	Mar 21
Form 3	—	—	—	—	Oct 01, 2021	5.63M	—	—	—

Showing 4 results

SOLENO THERAPEUTICS INC

Investor

Updated Oct 02, 2023

View Quote Details


Form 4	—	—	$1.75	$1.91M	Oct 02, 2023	2.29M	Options	—	Sep 28
Form 4	—	2.87M	$0.44	$1.27M	May 10, 2023	2.87M	Purchase	—	May 08
Form 4	150.98%	15.55M	—	—	Mar 31, 2022	25.86M	Purchase	—	Dec 21 - Mar 29
Form 4	47.83%	3.33M	$1.65	$5.50M	Jul 06, 2020	10.30M	Purchase	—	Jun 26
Form 4	49.26%	2.30M	$1.20	$2.76M	Oct 29, 2019	6.97M	Purchase	—	Oct 25
Form 3	—	—	—	—	Dec 27, 2018	4.67M	—	—	—

Showing 6 results

eFFECTOR Therapeutics, Inc.

Investor

Updated Dec 17, 2021

View Quote Details


Form 4	—	40.00K	—	—	Dec 17, 2021	40.00K	Grant	—	Oct 06
Form 3	—	—	—	—	Aug 27, 2021	4.82M	—	—	—

Showing 2 results

PROTEON THERAPEUTICS INC

Investor

Updated Nov 14, 2019

View Quote Details


Form 4	6.26%	126.52K	$0.99	$126.00K	Nov 14, 2019	2.15M	Options	—	Nov 12
Form 4	—	12.70K	—	—	Jun 11, 2018	12.70K	Grant	—	Jun 08
Form 4	—	2.53K	$1,000.00	$2.53M	Jun 26, 2017	2.53K	Purchase	—	Jun 22
Form 4	—	6.67K	—	—	Jun 21, 2017	6.67K	Grant	—	Jun 20
Form 4	—	6.67K	—	—	Jun 14, 2016	6.67K	Grant	—	Jun 09
Form 4	—	6.67K	—	—	Jun 03, 2015	6.67K	Acq/Dis	—	Jun 02
Form 4	-93.01%	-26.86M	$10.00	—	Oct 29, 2014	2.02M	Buy-Options	—	Oct 27
Form 3	—	—	—	—	Oct 21, 2014	—	—	—	—

Showing 8 results

CHIASMA, INC

Investor

Updated Mar 09, 2016


Form 4/A	-16.67%	-520.15K	—	—	Mar 09, 2016	2.60M	Options	—	Jul 15
Form 4	—	—	—	—	Jul 17, 2015	2.60M	Options	—	Jul 15
Form 3	—	—	—	—	Jul 16, 2015	—	—	—	—

Showing 3 results